NCT01398293View on ClinicalTrials.gov

A Study of Danoprevir in Combination With Low-Dose Ritonavir in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy Volunteer
Interventions
DRUG

danoprevir

100 mg single dose orally

DRUG

danoprevir

400 mg single dose orally

DRUG

danoprevir placebo

single oral dose

DRUG

moxifloxacin

400 mg single dose orally

DRUG

moxifloxacin placebo

single oral dose

DRUG

ritonavir

100 mg single dose orally

DRUG

ritonavir placebo

single oral dose

Trial Locations (1)

67064

Strasbourg

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01398293 - A Study of Danoprevir in Combination With Low-Dose Ritonavir in Healthy Subjects | Biotech Hunter | Biotech Hunter